In ER-positive, “immune-cold” breast cancers, letrozole attacks against estrogen regulation causerapid recruiting of dense immune cell infiltration and copious cytokine secretion, upregulating aromatase expression and estrogen synthesis. The gene discussed is ESR1; the disease is breast carcinoma.